FDGKX
Price
$41.42
Change
+$0.10 (+0.24%)
Updated
Oct 17 closing price
Net Assets
10.02B
VSTSX
Price
$313.67
Change
+$1.37 (+0.44%)
Updated
Oct 17 closing price
Net Assets
2.02T
Interact to see
Advertisement

FDGKX vs VSTSX

Header iconFDGKX vs VSTSX Comparison
Open Charts FDGKX vs VSTSXBanner chart's image
Fidelity Dividend Growth K
Price$41.42
Change+$0.10 (+0.24%)
VolumeN/A
Net Assets10.02B
Vanguard Total Stock Mkt Idx Instl Sel
Price$313.67
Change+$1.37 (+0.44%)
VolumeN/A
Net Assets2.02T
FDGKX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
FDGKX vs. VSTSX commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDGKX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. FDGKX (10B). VSTSX pays higher dividends than FDGKX: VSTSX (1.15) vs FDGKX (0.80). FDGKX was incepted earlier than VSTSX: FDGKX (17 years) vs VSTSX (9 years). FDGKX (0.80) is less costly to investors than VSTSX (0.01). FDGKX is a more actively managed with annual turnover of: 81.00 vs. VSTSX (2.00). FDGKX has a lower initial minimum investment than VSTSX: FDGKX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 13.82 vs. FDGKX (6.94). VSTSX return over 5 years is better than : 85.01 vs. FDGKX (60.24).
FDGKXVSTSXFDGKX / VSTSX
Total Expense Ratio0.800.018,000%
Annual Report Gross Expense Ratio0.800.018,000%
Fund Existence17 years9 years-
Gain YTD9.59613.02974%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets10B2.02T0%
Annual Yield % from dividends0.801.1570%
Returns for 1 year6.9413.8250%
Returns for 3 years56.3476.1674%
Returns for 5 years60.2485.0171%
Returns for 10 years47.76N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP3.700.27
+7.87%
Indaptus Therapeutics Inc
APPN28.150.36
+1.30%
Appian Corp
IONS73.090.02
+0.03%
Ionis Pharmaceuticals
LGO1.29-0.03
-2.27%
Largo
FDMT9.84-0.25
-2.48%
4D Molecular Therapeutics